EUVIMEDEUVIMED entdecken
Open Access

Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners

Elan Hahn, Bin Xu, Nora Katabi, Snjezana Dogan, Stephen M Smith, Bayardo Perez-Ordonez, Paras B Patel, Christina MacMillan, Daniel J Lubin, Jeffrey Gagan, Ilan Weinreb, Justin A Bishop

Modern Pathology · 2023-11 · 36 (11) · 100305

DOI: 10.1016/j.modpat.2023.100305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023-11. Verfasst von Elan Hahn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, U…. Hauptthemen laut MEDLINE: Adenocarcinoma, Salivary Gland Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymorphous adenocarcinoma (PAC) is a common, usually low-grade salivary gland carcinoma. While conventional PACs are most associated with PRKD1 p.E710D hotspot mutations, the cribriform subtype is often associated with gene fusions in PRKD1, PRKD2, or PRKD3. These fusions have been primarily identified by fluorescence in situ hybridization (FISH) analysis, with a minority evaluated by next-generation sequencing (NGS). Many of the reported fusions were detected by break-apart FISH probes and therefore have unknown partners or were negative by FISH altogether. In this study, we aimed to further characterize the fusions associated with PAC with NGS. Fifty-four PACs (exclusively cribriform and mixed/intermediate types to enrich the study for fusion-positive cases) were identified and subjected to NGS. Fifty-one cases were successfully sequenced, 28 of which demonstrated gene fusions involving PRKD1, PRKD2, or PRKD3. There were 10 cases with the PRKD1 p.E710D mutation. We identified a diverse group of fusion partners, including 13 novel partners, 3 of which were recurrent. The most common partners for the PRKD genes were ARID1A and ARID1B. The wide variety of involved genes is unlike in other salivary gland malignancies and warrants a broader strategy of sequencing for molecular confirmation for particularly challenging cases, as our NGS study shows.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaSalivary Gland NeoplasmsHumansIn Situ Hybridization, FluorescenceMutationGene Fusion

Stichwörter der Autor:innen

PRKDcribriformgene fusionshead and neck pathologymolecular pathologypolymorphous adenocarcinomasalivary gland tumors

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada. Electronic address: elan.hahn@s…
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.
  • ProPath, Dallas, Texas.
  • Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Hahn, E., Xu, B., Katabi, N., Dogan, S., Smith, S. M., Perez-Ordonez, B., Patel, P. B., MacMillan, C., Lubin, D. J., Gagan, J., Weinreb, I., & Bishop, J. A. (2023). Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners. Modern Pathology, 36(11), 100305. https://doi.org/10.1016/j.modpat.2023.100305

Vancouver

Hahn E, Xu B, Katabi N, Dogan S, Smith SM, Perez-Ordonez B, et al. Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners. Modern Pathology. 2023;36(11):100305. doi:10.1016/j.modpat.2023.100305

BibTeX
@article{Hahn2023,
  author = {Hahn, Elan and Xu, Bin and Katabi, Nora and Dogan, Snjezana and Smith, Stephen M and Perez-Ordonez, Bayardo and Patel, Paras B and MacMillan, Christina and Lubin, Daniel J and Gagan, Jeffrey and Weinreb, Ilan and Bishop, Justin A},
  title = {Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners},
  journal = {Modern Pathology},
  year = {2023},
  volume = {36},
  number = {11},
  pages = {100305},
  doi = {10.1016/j.modpat.2023.100305}
}
Kostenlos starten →